SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001628280-24-007392
Filing Date
2024-02-28
Accepted
2024-02-28 07:25:19
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 nautilusbiotechnology-sx3.htm S-3 440207
2 EX-FILING FEES exhibit107-sx3.htm EX-FILING FEES 43023
3 EX-1.2 exhibit12-sx3.htm EX-1.2 291253
4 EX-4.4 exhibit44-sx3.htm EX-4.4 424711
5 EX-5.1 exhibit51-sx3.htm EX-5.1 33434
6 EX-23.1 exhibit231-sx3.htm EX-23.1 3010
7 nautilus_primarylogoxblue.jpg GRAPHIC 291090
8 nautiluslogoa.jpg GRAPHIC 24277
9 picture1.jpg GRAPHIC 60785
  Complete submission text file 0001628280-24-007392.txt   1728426
Mailing Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102 206-333-2001
Nautilus Biotechnology, Inc. (Filer) CIK: 0001808805 (see all company filings)

IRS No.: 981541723 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-277437 | Film No.: 24690165
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)